glp-1 news nov 2025 Drug Side Effects May Be Tackled with More Mechanistic Studies Understanding GLP-1s and their dynamic

I chose these GLP-1 must-haves because they support the parts of the journey people often forget to plan for: hydration, protein, safe supply storage, symptom notes, food noise tracking, progress tracking, and provider-prep organization

Being aware of these can help you manage your treatment more effectively and know when to seek support

Two common GLP-1 agonists are: Semaglutide Sold under the brand names Wegovy and Ozempic , semaglutide is FDA-approved for weight loss and diabetes management

Retatrutide should not be used during pregnancy or whilst breastfeeding, as safety data in these populations are not available

Tosin, is a triple board-certified internal medicine, obesity medicine, and lifestyle medicine physician and a Fellow of the American College of Physicians, with over twenty years of clinical experience

As users chase the promise of rapid weight loss, the impact of these medications on the delicate balance of the gut microbiome has become increasingly apparent, raising concerns about potential long-term effects on digestive function and overall health